Janet Horsman

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

B. W. Hancock, Keith Wheatley, SyedHasan Harris et al. · Journal of Clinical Oncology · 2003 · 223 citations · Full text

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

J. Lester, David Dodwell, O.P. Purohit et al. · Clinical Cancer Research · 2008 · 189 citations

Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium

Ruyi Huang, Yongyue Wei, Rayjean J. Hung et al. · EBioMedicine · 2015 · 85 citations · Full text

Primary bone lymphoma: A retrospective analysis

Janet Horsman, Joel Thomas, Rachael Hough et al. · International Journal of Oncology · 2006 · 77 citations · Full text

Bone Disease, Lymphoid Neoplasia, Surgical Oncology +14

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours

Fieke E. M. Froeling, Ramya Ramaswami, Panagiotis Papanastasopoulos et al. · British Journal of Cancer · 2019 · 75 citations · Full text